NLNK - NewLink Genetics Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 0.99
52-Week Change 3-12.29%
S&P500 52-Week Change 318.19%
52 Week High 32.2700
52 Week Low 31.1300
50-Day Moving Average 31.5515
200-Day Moving Average 31.5727

Share Statistics

Avg Vol (3 month) 3268.36k
Avg Vol (10 day) 3160.78k
Shares Outstanding 537.31M
Float 25.94M
% Held by Insiders 122.52%
% Held by Institutions 134.73%
Shares Short (Nov 15, 2019) 41.88M
Short Ratio (Nov 15, 2019) 46.22
Short % of Float (Nov 15, 2019) 46.49%
Short % of Shares Outstanding (Nov 15, 2019) 45.03%
Shares Short (prior month Oct 15, 2019) 41.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-5,899.43%

Management Effectiveness

Return on Assets (ttm)-21.14%
Return on Equity (ttm)-43.42%

Income Statement

Revenue (ttm)705k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)105.00%
Gross Profit (ttm)-32.72M
EBITDA -40.91M
Net Income Avi to Common (ttm)-45.29M
Diluted EPS (ttm)-1.2150
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)98.53M
Total Cash Per Share (mrq)2.64
Total Debt (mrq)1.99M
Total Debt/Equity (mrq)2.30
Current Ratio (mrq)7.31
Book Value Per Share (mrq)2.32

Cash Flow Statement

Operating Cash Flow (ttm)-23.49M
Levered Free Cash Flow (ttm)-4.77M